Advancements in Biocompatible Artificial Heart Technology and Future Prospects | Stéphane Piat, CEO, Carmat SA. 00:10:00

Share On Facebook Share On Twitter

The CEO of a leading biotech company discusses the development of a biocompatible artificial heart to address the shortage of donor hearts, emphasizing its advantages over existing solutions and outlining future plans and financial outlook.

Recent Videos